Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-09-30 4:03 pm Purchase | 13G | ALLAKOS INC ALLK | Deep Track Capital LP | 4,518,575 5.33% | 4,518,575 (New Position) | View |
2022-09-23 4:11 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Deep Track Capital LP | 3,374,394 5.34% | 3,374,394 (New Position) | View |
2022-09-19 4:07 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Deep Track Capital LP | 699,281 9.99% | 699,281 (New Position) | View |
2022-09-16 4:08 pm Purchase | 13G | IVERIC BIO INC ISEE | Deep Track Capital LP | 9,000,000 7.62% | 9,000,000 (New Position) | View |
2022-09-12 4:19 pm Purchase | 13G | ARDELYX INC ARDX | Deep Track Capital LP | 14,252,831 8.45% | 14,252,831 (New Position) | View |
2022-08-22 4:16 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | Deep Track Capital LP | 3,684,619 9.99% | 3,684,619 (New Position) | View |
2022-08-22 4:13 pm Purchase | 13G | SILENCE THERAPEUTICS PLC SPONS SLN | Deep Track Capital LP | 5,854,740 5.44% | 5,854,740 (New Position) | View |
2022-08-19 4:03 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | Deep Track Capital LP | 12,232,267 9.99% | 12,232,267 (New Position) | View |
2022-07-07 09:24 am Purchase | 13G | 89BIO INC ETNB | Deep Track Capital LP | 4,331,499 9.99% | 4,331,499 (New Position) | View |
2022-06-23 4:01 pm Purchase | 13G | NUVATION BIO INC NUVB | Deep Track Capital LP | 11,471,281 5.26% | 11,471,281 (New Position) | View |
2022-06-17 4:04 pm Purchase | 13G | GLOBAL BLOOD THERAPEUTICS INC GBT | Deep Track Capital LP | 3,646,690 5.6% | 3,646,690 (New Position) | View |
2022-06-10 4:02 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital LP | 2,436,164 5.19% | 2,436,164 (New Position) | View |
2022-06-03 4:12 pm Purchase | 13G | FORMA THERAPEUTICS HLDGS INC FMTX | Deep Track Capital LP | 2,686,655 5.62% | 2,686,655 (New Position) | View |
2022-05-19 4:10 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Deep Track Capital LP | 917,825 5.37% | 917,825 (New Position) | View |
2022-05-16 4:55 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 3,435,200 5.41% | 985,200 (+40.21%) | View |
2022-04-18 4:15 pm Purchase | 13G | INOZYME PHARMA INC INZY | Deep Track Capital LP | 3,250,000 8.11% | 3,250,000 (New Position) | View |
2022-04-08 4:34 pm Purchase | 13G | AGENUS INC AGEN | Deep Track Capital LP | 15,229,187 5.92% | 15,229,187 (New Position) | View |
2022-03-04 4:10 pm Purchase | 13G | HOOKIPA PHARMA INC HOOK | Deep Track Capital LP | 5,035,998 9.9% | 5,035,998 (New Position) | View |
2022-02-18 4:11 pm Purchase | 13G | NKARTA INC NKTX | Deep Track Capital LP | 1,965,684 5.97% | 1,965,684 (New Position) | View |
2022-02-16 4:46 pm Purchase | 13G | CHINOOK THERAPEUTICS INC KDNY | Deep Track Capital LP | 2,752,070 5.04% | 2,752,070 (New Position) | View |